189 related articles for article (PubMed ID: 25445949)
1. Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment.
Sitbon O; Bertoletti L
Eur Respir Rev; 2014 Dec; 23(134):505-9. PubMed ID: 25445949
[No Abstract] [Full Text] [Related]
2. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 1. Pulmonary hypertension associated with connective tissue diseases].
Tanaka S
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2613-20. PubMed ID: 24400542
[No Abstract] [Full Text] [Related]
3. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary arterial hypertension in connective tissue diseases].
Degano B
Rev Mal Respir; 2006 Dec; 23(6):746-8. PubMed ID: 17886350
[No Abstract] [Full Text] [Related]
5. Pulmonary hypertension in connective tissue diseases: an update.
Aithala R; Alex AG; Danda D
Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
[TBL] [Abstract][Full Text] [Related]
6. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
Coghlan JG; Pope J; Denton CP
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S27-34. PubMed ID: 20375662
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
Sanchez O; Sitbon O; Jaïs X; Simonneau G; Humbert M
Chest; 2006 Jul; 130(1):182-9. PubMed ID: 16840400
[TBL] [Abstract][Full Text] [Related]
9. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
[TBL] [Abstract][Full Text] [Related]
10. Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.
Fischer A; Denton CP; Matucci-Cerinic M; Gillies H; Blair C; Tislow J; Nathan SD
Respir Med; 2016 Aug; 117():254-63. PubMed ID: 27492539
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Sitbon O; Simonneau G
Chest; 1998 Jul; 114(1 Suppl):80S-82S. PubMed ID: 9676646
[No Abstract] [Full Text] [Related]
12. Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
Dardi F; Manes A; Palazzini M; Bachetti C; Mazzanti G; Rinaldi A; Albini A; Gotti E; Monti E; Bacchi Reggiani ML; Galiè N
Eur Respir J; 2015 Aug; 46(2):414-21. PubMed ID: 26022952
[TBL] [Abstract][Full Text] [Related]
13. Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension.
Hanaoka H; Ishigaki S; Takei H; Hiramoto K; Saito S; Kondo Y; Kikuchi J; Kaneko Y; Takeuchi T
Int J Rheum Dis; 2021 Nov; 24(11):1419-1426. PubMed ID: 34626090
[TBL] [Abstract][Full Text] [Related]
14. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
Yoshifuji H; Kinoshita H
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129
[TBL] [Abstract][Full Text] [Related]
15. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
16. New horizons in pulmonary arterial hypertension management.
McLaughlin V; Simonneau G; Galiè N; Rubin LJ
Eur Respir Rev; 2014 Dec; 23(134):408-9. PubMed ID: 25445938
[No Abstract] [Full Text] [Related]
17. Pulmonary arterial hypertension associated to connective tissue diseases.
Galiè N; Manes A; Farahani KV; Pelino F; Palazzini M; Negro L; Romanazzi S; Branzi A
Lupus; 2005; 14(9):713-7. PubMed ID: 16218473
[TBL] [Abstract][Full Text] [Related]
18. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yasuoka H; Shirai Y; Tamura Y; Takeuchi T; Kuwana M
Circ J; 2018 Jan; 82(2):546-554. PubMed ID: 28904255
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of pulmonary hypertension in systemic sclerosis.
Preston IR; Hill NS
Curr Opin Rheumatol; 2003 Nov; 15(6):761-5. PubMed ID: 14569207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
